Related references
Note: Only part of the references are listed.Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity
Joel D. Pearson et al.
CANCER CELL (2021)
PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to Everolimus
Gabriel B. Mpilla et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms
Johannes Hofland et al.
ENDOCRINE REVIEWS (2020)
Mitochondrial TCA cycle metabolites control physiology and disease
Inmaculada Martinez-Reyes et al.
NATURE COMMUNICATIONS (2020)
A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma
Shumei Song et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lung
Sanjeeve Balasubramaniam et al.
ANTI-CANCER DRUGS (2018)
Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells
Kuo Du et al.
GASTROENTEROLOGY (2018)
A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors
Mariano J. Alvarez et al.
NATURE GENETICS (2018)
A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal
Guido Rindi et al.
MODERN PATHOLOGY (2018)
Hippo signaling dysfunction induces cancer cell addiction to YAP
Han Han et al.
ONCOGENE (2018)
The Ambivalent Function of YAP in Apoptosis and Cancer
Xianbin Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Multilayered heterogeneity as an intrinsic hallmark of neuroendocrine tumors
Sergio Pedraza-Arevalo et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2018)
Riboflavin and health: A review of recent human research
Kiran Thakur et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2017)
Riboflavin deficiency induces a significant change in proteomic profiles in HepG2 cells
Zhonghao Xin et al.
SCIENTIFIC REPORTS (2017)
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
Lauren Fishbein et al.
CANCER CELL (2017)
Characterization of Hippo Pathway Components by Gene Inactivation
Steven W. Plouffe et al.
MOLECULAR CELL (2016)
A Phase II Trial of a Histone Deacetylase Inhibitor Panobinostat in Patients With Low-Grade Neuroendocrine Tumors
Ning Jin et al.
ONCOLOGIST (2016)
NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus
Carles Canto et al.
CELL METABOLISM (2015)
Depletion of the Central Metabolite NAD Leads to Oncosis-mediated Cell Death
Christopher Del Nagro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The human flavoproteome
Wolf-Dieter Lienhart et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2013)
Therapy innovations: tyrosine kinase inhibitors for the treatment of pancreatic neuroendocrine tumors
Eric Raymond et al.
CANCER AND METASTASIS REVIEWS (2011)
Chemical Genomics Profiling of Environmental Chemical Modulation of Human Nuclear Receptors
Ruili Huang et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2011)
Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers
Anna Imhof et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A Pilot Phase II Study of Valproic Acid for Treatment of Low-Grade Neuroendocrine Carcinoma
Tabraiz A. Mohammed et al.
ONCOLOGIST (2011)
Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin
Bristi Basu et al.
ENDOCRINE-RELATED CANCER (2010)
Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
Edoardo Missiaglia et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Both TEAD-Binding and WW Domains Are Required for the Growth Stimulation and Oncogenic Transformation Activity of Yes-Associated Protein
Bin Zhao et al.
CANCER RESEARCH (2009)
Gastroenteropancreatic neuroendocrine tumours
Irvin M. Modlin et al.
LANCET ONCOLOGY (2008)
Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical libraries
James Inglese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours
T Aparicio et al.
EUROPEAN JOURNAL OF CANCER (2001)
Chemotherapy in the treatment of neuroendocrine malignant tumors
P Rougier et al.
DIGESTION (2000)
Share Paper
